Recent Updates
Recently added Catalysts
Octagon Capital Advisors LP
Track Octagon Capital Advisors LP's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Oct 8, 2026
Showing 6 Stocks Out Of 26. Click On The Tickers For More Details
| Stock | Compnay Name | Shares Held | Market Value | % of Portfolio | QoQ Change |
|---|---|---|---|---|---|
 DFTX | DEFINIUM THERAPEUTICS INC | 2.95 M | 138.77 M | 12.5 | |
 ERAS | ERASCA INC | 1.25 M | 22.99 M | 2.1 | |
 FTH | FAETH THERAPEUTICS INC | 361.01 K | 9.03 M | 0.8 | |
 KYMR | KYMERA THERAPEUTICS INC | 310.00 K | 35.55 M | 3.2 | |
 DNTH | DIANTHUS THERAPEUTICS INC | 1.84 M | 179.53 M | 16.1 | |
 TRVI | TREVI THERAPEUTICS INC | 315.00 K | 5.87 M | 0.5 |
Market Value
$ 1.08 B
Holdings
26
Period
Q2 2026
Holdings in Top 20
%
QoQ Changes
23.12 %